Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pain Therapeutics (PTIE)

7.7 -0.29 (-3.63%)

04-18 16:00

Open:

7.84

Pre. Close:

7.99

High:

7.9512

Low:

7.35

Volume:

70,500

Market Cap:

53M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.967 - 8.015

8.015 - 8.05

Low:

7.242 - 7.302

7.302 - 7.347

Close:

7.618 - 7.71

7.71 - 7.779

Technical analysis  (as of: 2018-04-18 4:43:40 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 10.06     One year: 11.75

Support:

Support1: 7.25    Support2: 6.41

Resistance:

Resistance1: 8.61    Resistance2: 10.06

Pivot:

7.52

Moving Averages:

MA(5): 8.12     MA(20): 7.33

MA(100): 6.18     MA(250): 4.85

MACD:

MACD(12,26): 0.32     Signal(12,26,9): 0.26

%K %D:

%K(14,3): 69.33     %D(3): 81.02

RSI:

RSI(14): 55.28

52-Week:

High: 12.8  Low: 3.1  Change(%): 39.2

Average Vol(K):

3-Month: 9151  10-Days 5941

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PTIE has closed below upper band by 41.7%. Bollinger Bands are 10.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices

2018-03-20T08:00:00-04:00
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER

2018-03-19T11:36:00-04:00
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pain Therapeutics, Inc.

2018-03-19T10:42:39-04:00
Ad Com June 26 for Pain Therapeutics' Remoxy ER

2018-03-19T07:33:00-04:00
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Pain Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

2018-03-19T04:25:51-04:00
Trump to release opioid epidemic plan

2018-03-08T03:17:51-05:00
Opioid settlement talks hit roadblocks

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

6.90

Shares Float (M)

1.23

% Held by Insiders

85.90

% Held by Institutions

33.60

Shares Short (K)

718

Shares Short Prior Month (K)

893

Stock Financials

EPS

-1.830

EPS Est. Current Year

-2.350

EPS Est. Next Year

-2.600

EPS Est. Next Quarter

Forward EPS

-1.650

Book Value (p.s.)

6.050

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-79.1

Return on Equity (ttm)

-84.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.723

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.24

Levered Free Cash Flow (M)

-3.79

atoplab.com

Valuation

P/E

-4.21

P/E Growth Ratio

-0.04

P/BV

1.27

P/S

P/CF

-6.44

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-12-24

Ex-Dividend Date

2012-12-13

Forward Dividend

Last Split Date

2017-05-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.